Literature DB >> 22356708

[Investigation of occupational health status of female workers in pharmaceutical industry of Shandong and Gansu provinces].

Wen-Lan Yu1, Jian-Jiao Zhou, Jian-Fang Zou, Zhen-Xia Kou, Ming Xu, Xiao-Shuang Xie, An-Shou Zhou.   

Abstract

OBJECTIVE: To investigate occupational health status of female workers in pharmaceutical industries and to propose the protective measures for the occupational health.
METHOD: A total of 2816 female workers from 19 pharmaceutical industries in Shandong and Gansu provinces were investigated by a questionnaire.
RESULTS: 73.1% of female workers exposed to occupational hazards, mainly to toxic chemicals. 63.2% of them suffered from dysmenorrhea; 38.5% of them have reproductive system diseases, i.e. mammary gland hyperplasia (44.1%), cervical erosion (26.5%), uterine annex inflammation (24.2%); 17.1% of them suffered from accidental work injuries; 34.7% of them complained about low back pain, and 29.7% of them perceived hearing loss. 94.9% of female workers hoped to get the occupational health and labor protection knowledge and skills.
CONCLUSION: Strengthening the supervision of labor protection for female workers, including technical measures occupational hazards control and health-related knowledge, and improving the occupational health status of female workers should be conducted.

Entities:  

Mesh:

Year:  2011        PMID: 22356708     DOI: 10.3760/cma.j.issn.1001-9391.2011.09.004

Source DB:  PubMed          Journal:  Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi        ISSN: 1001-9391


  2 in total

1.  The risk of using intrauterine devices to benign reproductive system conditions in postmenopausal women: A case control study.

Authors:  Xiaohua Zhang; Liping Xiao; Haoping Zhu; Linan Cheng
Journal:  J Res Med Sci       Date:  2016-03-15       Impact factor: 1.852

Review 2.  Reproductive Toxic Chemicals at Work and Efforts to Protect Workers' Health: A Literature Review.

Authors:  Kyung-Taek Rim
Journal:  Saf Health Work       Date:  2017-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.